Financial

TransEnterix Acquires Assets, Intellectual Property and Retains R&D Team from MST Medical Surgery Technologies

September 23, 2018 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has acquired substantially all of the assets of MST Medical Surgery Technologies Ltd. (“MST”), an Israel medical technology company, in a

By |2018-09-24T16:23:30+00:00September 24th, 2018|Financial|

Medtronic to Acquire Mazor Robotics

DUBLIN and CAESAREA, Israel - September 20, 2018 - Medtronic plc (NYSE:MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of robotic guidance systems, today announced the companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding ordinary shares of Mazor for $58.50

By |2018-09-21T16:08:08+00:00September 21st, 2018|Financial, Robotics, Top Stories|

Providence Medical Technology Secures $25 Million In Equity Financing

PLEASANTON, Calif., Sept. 20, 2018 /PRNewswire/ -- Providence Medical Technology, Inc., an innovator in tissue-sparing surgical equipment and implants for cervical spine fusion surgery, today announced the closing of $25 million in new equity financing. Revelation Partners led the round with participation from the private equity investment team at BMO Global Asset Management (EMEA), MVM Life Science Partners, Medvest Capital,

By |2018-09-20T22:01:42+00:00September 20th, 2018|Financial|

Ortho Regenerative Technologies Inc. Appoints Accomplished Life Science Executive, Luc Mainville, as CFO

KIRKLAND, Quebec, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. (“Ortho RTi” or the “Corporation”) (CSE: ORTH) today announced the appointment of Luc Mainville as Senior Vice President and Chief Financial Officer, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning, as well as helping to manage the Corporation’s relationships

By |2018-09-20T21:50:03+00:00September 20th, 2018|Financial|

Implanet Publishes Its Interim 2018 Results

September 19, 2018 BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: Implanet (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans; OTCQX: IMPZY) (Paris:ALIMP) (OTCQX:IMPZY), a medical technology company specializing in vertebral and knee surgery implants, has announced its interim results for the six-month period ended June 30, 2018, as approved by the Board of Directors on September

By |2018-09-19T22:05:13+00:00September 19th, 2018|Financial|

SPINEWAY : Early redemption of 44 ORNANE Notes End of bond financing by ORNANE

 Ecully, 19 September 2018 Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), announces the early redemption of 44 notes redeemable in cash and/or convertible into new and/or existing shares (the "Notes") and the end of the financing via issuance of Notes set up on 28 July 2017 with

By |2018-09-19T18:24:17+00:00September 19th, 2018|Financial|

Medicrea Reports First Half 2018 Results

September 19, 2018 LYON, France & NEW YORK--(BUSINESS WIRE)--The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the transformation of spinal surgeries through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) technology, has today published its unaudited results for the

By |2018-09-19T15:35:27+00:00September 19th, 2018|Financial|

SpineGuard Reports Six-Month 2018 Financial Results

September 18, 2018 PARIS & SAN FRANCISCO--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that designs, develops, and markets disposable medical devices intended to make spine surgery safer by bringing real-time digital technology into the operating room, announced today financial results for the half year ending June 30, 2018, as approved by

By |2018-09-19T15:21:25+00:00September 19th, 2018|Financial|

Zavation Medical Products, LLC, a LongueVue Capital Portfolio Company, Completes Investment in Pan Medical U.S. Corp.

JACKSON, Miss., Sept. 18, 2018 /PRNewswire/ -- Zavation Medical Products ("Zavation"), a LongueVue Capital ("LVC") portfolio company, is pleased to announce it has partnered with the management team of Pan Medical U.S. Corp ("PanMed" or the "Company") to acquire the Company. This partnership broadens Zavation's service offering by adding a full suite of minimally invasive products, including the

By |2018-09-18T17:30:52+00:00September 18th, 2018|Financial|

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2018

WARSAW, Ind., Sept. 13, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2018. The cash dividend of $0.24 per share is payable on October 31, 2018 to stockholders of record

By |2018-09-14T22:08:03+00:00September 14th, 2018|Financial|